United States
Aoxing Pharmaceutical Company, Inc.
Aoxing Pharmaceutical Company, Inc. is a specialty pharmaceutical company focused on the research, development, manufacturing, and distribution of narcotic, pain-management, and addiction treatment pharmaceutical products, primarily in the People’s Republic of China.
Key Products
- Zhongtong'an: A capsule of herbal extraction for oral and dental pain relief.
- Yiqi Qiangshen Granule: An OTC herbal extraction designed to tonify qi, empower the body, and promote blood circulation.
- Tilidine Hydrochloride: A synthetic narcotic analgesic tablet (50mg or 100mg) used for acute, moderate to severe pain, and chronic cancer-related pain.
Products Under Development
- Oxycodone and Acetaminophen: Tablets and capsules for acute and chronic pain (completed clinical trials).
- Buprenorphine/Naloxone: A sublingual combo tablet for opioid dependence (completed Phase II trials).
- Tilidine/Naloxone: A compound capsule for acute and chronic pain (Phase II clinical trial).
Corporate Background
Formerly known as China Aoxing Pharmaceutical Company, Inc., the company changed its name to Aoxing Pharmaceutical Company, Inc. in March 2010. It is headquartered in Shijiazhuang, China.
